ACADIA Pharmaceuticals Inc (ACAD)
Fixed asset turnover
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Revenue | US$ in thousands | 957,797 | 726,437 | 517,235 | 484,145 | 441,755 |
| Property, plant and equipment | US$ in thousands | — | — | 61,594 | 66,315 | 9,161 |
| Fixed asset turnover | — | — | 8.40 | 7.30 | 48.22 |
December 31, 2024 calculation
Fixed asset turnover = Revenue ÷ Property, plant and equipment
= $957,797K ÷ $—K
= —
Fixed asset turnover is a financial ratio that measures a company's ability to generate revenue from its investment in fixed assets. For ACADIA Pharmaceuticals Inc, the fixed asset turnover has shown fluctuation over the years.
In December 31, 2020, the fixed asset turnover was exceptionally high at 48.22, indicating that the company generated significant revenue relative to its investment in fixed assets. However, this ratio dropped substantially to 7.30 by December 31, 2021. Such a sharp decline could indicate either a decrease in revenue generated from fixed assets or a significant increase in the value of fixed assets, affecting the ratio negatively.
In the following years, the fixed asset turnover improved slightly to 8.40 by December 31, 2022. The lack of data for December 31, 2023, and December 31, 2024 make it challenging to assess the trend further, as it could be due to missing information or specific events affecting the company's financial reporting.
Overall, the fluctuation in ACADIA Pharmaceuticals Inc's fixed asset turnover suggests changes in the efficiency of utilizing fixed assets to generate revenue. Investors and analysts should monitor this ratio over time to assess the company's operational performance and capital allocation strategies.
Peer comparison
Dec 31, 2024